Contact allergy to miripirium chloride in Depo-Medrol.
Färm
G
G
Department of Dermatology, Orebro Medical Centre Hospital, Sweden.
Erikssohn
I
I
D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D017449:Dermatitis, Allergic Contact / Q000209:etiology*; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D006801:Humans; D007428:Intradermal Tests; D008775:Methylprednisolone / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077555:Methylprednisolone Acetate; D008875:Middle Aged; D009227:Myristic Acids / Q000009:adverse effects*; D010847:Picolines / Q000009:adverse effects*; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D009227:Myristic Acids; D010847:Picolines; D011310:Preservatives, Pharmaceutical; C054770:1-myristylpicolinium; D000077555:Methylprednisolone Acetate; D008775:Methylprednisolone